The World Health Organization has released its first-ever guidelines for treating obesity in adults. Obesity is now clearly defined as a chronic, relapsing disease. It is typically diagnosed when a person has a Body Mass Index, or BMI, of 30 or higher. BMI is calculated by dividing weight in kilograms by height in meters squared. Click this link to calculate your BMI.
The new WHO obesity guidelines include two key recommendations for long-term obesity treatment:
• Long-term use of GLP-1 therapy for adults living with obesity, defined as treatment for six months or longer.
• Intensive lifestyle intervention that includes structured nutrition counseling, healthy diet changes, and regular physical activity.
These recommendations reflect what obesity medicine experts already understand. Obesity develops from many complex factors. Genetics affect how the body stores fat, burns energy, and regulates hunger. Neurobiology also plays a role, as the systems that control energy balance may not function properly. Eating habits matter, but so does the environment. Many people lead busy lives shaped by stress, processed foods, and limited time for exercise. These factors increase the risk of weight gain and long-term obesity.
GLP-1 receptor agonists are FDA approved GLP-1 medications used to treat type 2 diabetes and support medical weight loss. These medicines help lower blood sugar, reduce appetite, slow digestion, and promote sustainable weight loss. Research shows they also reduce cardiovascular risk, improve kidney health, and support chronic disease prevention. For people with type 2 diabetes, GLP-1 therapy for weight loss may also lower the risk of early death.
GLP-1 therapies were first approved in 2005, and their role has expanded as research has grown. Studies show benefits for major cardiovascular events, heart failure, diabetes prevention, lower systolic blood pressure, improved LDL cholesterol, obstructive sleep apnea, chronic kidney disease, and fatty liver disease.
At 20/20 Lifestyles, we provide a comprehensive medical weight loss program in Bellevue, WA that aligns with WHO obesity guidelines. Our approach combines GLP-1 therapy, when appropriate, with intensive lifestyle intervention and personalized coaching. If you are searching for obesity treatment or GLP-1 therapy in Bellevue, WA, our team is here to help you achieve sustainable weight loss and long-term health.
This article was written by Dr. Padmini Nehru, Owner of PCN Medical PLLC and the 20/20 Lifestyles program. Dr. Nehru is dedicated to helping individuals improve their long-term health through personalized medical care, evidence-based lifestyle guidance, and a comprehensive approach to wellness.